On April 19th and May 3rd, 2022, the Simplify Prior Authorization (SPA) initiative hosted webinars for patient groups and advisors/plan sponsors on the Challenges and New Solutions in the Private Prior Authorization Landscape. Presenters included Rachael Manion, Executive Director of Canadian Skin Patient Alliance and Canadian Association of Psoriasis Patients, Alan Birch, Associate Director of Provider Solutions – Oncology with Sentrex and founder of Drug Access Canada, and Denise Balch, President of Connex Health.
Prior authorization is a process by which private payers (insurers and pharmacy benefit managers (PBMs)) reimburse a prescribed medication on the submission of satisfactory medical evidence from a patient and their physician according to criteria established by payers. Based on the 2019 White Paper from Connex Health and reinforced by presenters at the webinars, PA is time-consuming due to inefficiencies in the process that include:
As a result, patients can sometimes be left waiting weeks before they can start treatment. This can have a significant impact on patients. Not only can the administrative process be frustrating and stressful, for some, there is a risk of significant disease progression which can result in irreversible debilitation or exacerbation of their condition.
The public sector has traditionally faced similar process challenges. Recently there has been significant improvement in the public sector process through the implementation of Special Authorization Digital Information Exchange (SADIE), an electronic online submission tool which can process claims within 1-2 business days. The private sector has yet to see any updates of this kind.
In the original White Paper and through advocacy and outreach such as recent podcasts and webinars, the SPA initiative is advocating for the implementation of an agnostic and seamless, electronic process for reimbursement of PA claims. This enables healthcare practitioners, drug access navigators (DANs), some specialty pharmacies, and patient support programs (PSP) to complete and submit claim requirements electronically, including the collection of signatures, and required medical documentation. When payers receive the electronic submission, their PA team can review each claim submission and respond electronically, with an approval, request for additional information, or a decline.
An electronic PA process would not change the reimbursement decision, which would continue to be decided by payers. The criteria used to determine who qualifies for reimbursement would remain unchanged. However, an electronic prior authorization process (ePA) will decrease submission and wait times for payer decisions on reimbursement, while also reducing the administrative costs associated with the existing long and inefficient process. The overall result is a more efficient process for all stakeholders.
Polling during the recent webinars told us there is also a stakeholder education and information gap when it comes to PA:
Additional discussion and polling results show that the PA web resource under development by the SPA initiative through Connex Health, could fill at least some information gaps, links to PA resources/payer websites and education on specialty drugs and the claims process.
Full polling results can be found here.
The information provided by participants in these webinars reinforces the need to improve the PA process and provide additional online resources where stakeholders can access information and education on PA. The SPA initiative will be addressing the need for a web resource in the coming months and welcomes additional input on content from all PA stakeholders, including payers, so that we can maximize the value of this resource.
Thank you to everyone who joined us at these webinars.
All inquiries regarding the SPA initiative should be directed to info@simplifypriorauth.ca.
Read our new article in the May edition of the Benefits and Pension Monitor magazine, where we explore the history of prior authorization, specialty drug spend, new technologies and solutions to advance prior authorization.
Do you or your clients have specialty drug claims on group benefit plans? If so, you need to read this blog and find out about the new patient information and resources website.
The Simplify Prior Authorization (SPA) initiative recently hosted its first webinar in 2023 for group benefits stakeholders on new prior authorization (PA) resources and solutions. Interest was high, with the largest registration numbers since the initiative began.
The Simplify Prior Authorization initiative is an advocate for education about prior authorization (PA) and improvement in current prior authorization practices and processes. If your organization is interested in finding out more, getting involved, or in sponsorship of this important initiative, please contact us via the link below.
